| 21.45 Data as of Jun 19 |  -0.27 / -1.24%Today’s Change | 16.19 Today|||52-Week Range 23.05 | +5.93% Year-to-Date |
| Is Life Technologies Overvalued? Jun 19 / MotleyFool.com |
| Previous close | 21.72 |
| Today’s open | 21.74 |
| Day’s range | 21.42 - 21.74 |
| Volume | 94,959 |
| Average volume (3 months) | 164,407 |
| Market cap | $900.7M |
| Dividend yield | 3.54% |
| Earnings growth (last year) | +23.08% |
| Earnings growth (this year) | +8.72% |
| Earnings growth (next 5 years) | +17.00% |
| Revenue growth (last year) | +8.65% |
| P/E ratio | 25.2 |
| Price/Sales | 4.54 |
| Price/Book | 6.28 |
| Today’s change | Today’s % change | |
|---|---|---|
| QDELQuidel Corp | -0.46 | -1.81% |
| GHDXGenomic Health Inc | -0.50 | -1.47% |
| DNDNDendreon Corp | -0.09 | -2.21% |
| NEOGNeogen Corp | -0.81 | -1.46% |
| Next reporting date | July 18, 2013 |
| EPS forecast (this quarter) | $0.22 |
| Annual revenue (last year) | $173.5M |
| Annual profit (last year) | $33.4M |
| Net profit margin | 19.23% |
Sector Health Technology |
Industry Biotechnology |
Executive Chairman William J. Motto |
CEO, Director & Head-Media Relations John A. Kraeutler |
Corporate headquarters Cincinnati, Ohio |
.
